Severity of Gastrointestinal Bleeding in Obese vs. Non-Obese Veterans Taking Direct Oral Anticoagulants

被引:0
|
作者
Ahmad, Ammar [1 ]
Markert, Ronald [1 ]
Agrawal, Sangeeta [1 ]
机构
[1] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S688
引用
收藏
页码:S310 / S310
页数:1
相关论文
共 50 条
  • [41] Distinct Clinical and Genetic Features of Acute Myeloid Leukemia (AML) in Obese Vs. Non-Obese Patients: A Comparative Study
    Johnson, Anna
    Chahine, Zena
    Morris, Trevor
    Soule, Ashley
    Taj, Hiffsa
    McAvoy, Claire
    Zhou, Xitong
    Iragavarapu, Chaitanya
    Munker, Reinhold
    Monohan, Gregory
    Ramlal, Reshma
    Qasrawi, Ayman
    Yalniz, Fevzi
    BLOOD, 2023, 142
  • [42] Effectiveness of paliperidone palmitate one-month long-acting injection in obese vs. non-obese patients
    Dorflinger, Charles
    LeHew, Colleen
    Carey, Heather
    Roche-Desilets, Jennifer
    Burant, Christopher J.
    COMPREHENSIVE PSYCHIATRY, 2021, 111
  • [43] Differential prognostic impact of atrial fibrillation in non-obese vs. obese patients with heart failure with preserved ejection fraction
    Yagawa, M.
    Nagatomo, Y.
    Izumi, Y.
    Mahara, K.
    Shiraishi, Y.
    Inohara, T.
    Mizuno, A.
    Goda, A.
    Kohsaka, S.
    Yoshikawa, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 412 - 413
  • [44] Vitamin D status and response to vitamin D3 in obese vs. non-obese African American children
    Rajakumar, Kumaravel
    Fernstrom, John D.
    Holick, Michael E.
    Janosky, Janine E.
    Greenspan, Susan L.
    OBESITY, 2008, 16 (01) : 90 - 95
  • [45] SAFETY AND TOLERABILITY OF THE AGILE PATCH, A CONTRACEPTIVE PATCH WITH LOW-DOSE ETHINYL ESTRADIOL (EE) AND LEVONORGESTREL (LNG), VS. COMBINATION ORAL CONTRACEPTIVES (COCS) IN OBESE VS. NON-OBESE WOMEN
    Kaunitz, A. M.
    Archer, D. E.
    Foegh, M.
    FERTILITY AND STERILITY, 2012, 98 (03) : S195 - S196
  • [46] Blood pressure response to treatment of obese vs non-obese adults with sleep apnea
    Kuna, Samuel T.
    Townsend, Raymond R.
    Keenan, Brendan T.
    Maislin, David
    Gislason, Thorarinn
    Benediktsdottir, Bryndis
    Gudmundsdottir, Sigrun
    Arnardottir, Erna Sif
    Sifferman, Andrea
    Staley, Beth
    Pack, Frances M.
    Guo, Xiaofeng
    Schwab, Richard J.
    Maislin, Greg
    Chirinos, Julio A.
    Pack, Allan I.
    JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (10): : 1580 - 1590
  • [47] Effects of chronotherapeutic delivery of verapamil in obese vs non-obese patients with hypertension.
    White, WB
    Johnson, MF
    Fakouhi, TD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 131 - 131
  • [48] Direct oral anticoagulants in extremely obese patients: OK to use?
    Moll, Stephan
    Crona, Daniel J.
    Martin, Karlyn
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (02) : 152 - 155
  • [49] Association between direct oral anticoagulants and risk of gastrointestinal bleeding
    Chen, I. -Wen
    Kao, Chia -Li
    Ho, Chun-Ning
    Hung, Kuo-Chuan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 144 - 145
  • [50] C-Reactive Protein and Coronary Heart Disease Events in Obese vs. Non-Obese Individuals: The Dallas Heart Study
    Khera, Amit
    Neeland, Ian
    Berry, Jarett D.
    Ayers, Colbv A.
    Gupta, Nitin K.
    Abdullah, Shuaib A.
    Das, Sandeep R.
    Rohatgi, Anand A.
    McGuire, Darren K.
    de Lemos, James A.
    CIRCULATION, 2013, 127 (12)